Novo Nordisk (Denmark)

The effect of telemonitoring on quality of life in people with insulin‐treated type 2 diabetes: A secondary analysis of a randomised controlled trial

Abstract Aims Telemonitoring in type 2 diabetes (T2D) care has demonstrated positive trends in terms of glycaemic control. However, evidence regarding its impact on patient‐reported outcomes, such as general and diabetes‐specific quality of life (QoL), remains inconclusive. In pa...

Glucose in Motion: Characterizing Temporal Patterns in Real-World Glycemic Control in a Large Observational Cohort

OBJECTIVE: To identify and characterize daily and weekly patterns in glycemic management in longitudinal real-world continuous glucose monitoring (CGM) data from people with diabetes to enhance clinical interpretation and support more effective personalized diabetes management. R...

Quantifying the fiscal benefits of obesity prevalence reduction in China

With obesity becoming increasingly prevalent in China, its impact extends beyond health losses to wider public finance pressures. This study assessed the fiscal implications of reducing obesity prevalence from the government perspective and explored the potential fiscal benefits...